Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010205

Options or other derivatives

  • Director acquired 96,590 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RECTOR DAVID · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-19 Grant or award : show line 1 in the form Common Stock Options +96,590 $0.13 2023-02-19 96,590 1,460,579 D
Loading xslF345X03/form457958_20130220030120-.xml…